NEWS

March 12, 2021
Bill Padula

Monument Analytics Principal Dr. Bill Padula was quoted in The Marin Independent Journal article titled: “COVID vaccines: Will California meet Biden’s May 1 goal?” Dr. Padula shared his views regarding logistics of vaccine distribution in California.

March 10, 2021
Bill Padula

Monument Analytics Principal Dr. Bill Padula was quoted in The Marin Independent Journal article titled: “Tensions mount over California’s vaccine distribution plan.” Dr. Padula shared his views regarding public and private vaccine distribution in California.

March 9, 2021
Bill Padula

Monument Analytics Principal Dr. Bill Padula was quoted in The Mercury News article titled: “COVID: Will revolt over Blue Shield cost Santa Clara County access to vaccine?” Dr. Padula shared his views regarding public and private partnerships for vaccine distribution.

March 5, 2021
Caleb Alexander

Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in an article in Law360 titled: “Opioid Litigation Is Prying Open Vaults Of Big Pharma Secrets.” The article discussed ongoing opioid litigation and parallels to tobacco litigation.

February 23, 2021
Monument Analytics: Bill Padula, Natalie Reid, Jon Tierce

Monument Analytics team members co-authored a Value & Outcomes Spotlight titled: “Health Technology Assessment for COVID-19 Treatments and Vaccines: Will Cost-Effectiveness Analysis Serve Our Needs?

February 19, 2021
Caleb Alexander

Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was interviewed by Healio Rheumatology about his publication in Clinical Infectious Diseases titled: “Association Between Chronic Use of Immunosuppressive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System.” This research study showed that individuals taking chronic immunosuppressive medications do not fare worse in terms of COVID outcomes.

February 9, 2021
Bill Padula
Monument Analytics Principal Dr. Bill Padula and Advisory Board Member Dr. Mark Sculpher co-authored a white paper titled: “Health Technology Assessment in the U.S. a Vision for the Future” as part of the USC Schaeffer Center – Aspen Institute Advisory Panel on Health Technology Assessment in the U.S.

February 4, 2021
Caleb Alexander

Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in a Financial Times article titled: “Opioid crisis haunts frontrunner for top job at US drugs regulator” for his perspectives regarding the FDA’s role in the opioid epidemic.

January 30, 2021
Caleb Alexander

Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in a Bloomberg News article titled: “Biogen Alzheimer’s Drug Puts FDA’s Judgment in Harsh Spotlight” for his views regarding the regulatory review of aducanumab.

January 20, 2021
Bill Padula
Monument Analytics Principal Dr. Bill Padula was elected 2021 President of the National Pressure Injury Advisory Panel.

January 2, 2021
Caleb Alexander

Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in an article in The Economist titled: “The other epidemic: The Justice Department accuses Walmart of fuelling the opioid crisis.” The article discussed the severity of the ongoing opioid epidemic.

November 27, 2020
Caleb Alexander
Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in a Politico article titled: “Transition 2020: Biden’s other health crisis: A resurgent drug epidemic” for progress made and hindered in the opioid epidemic by the COVID-19 pandemic.

November 18, 2020
Bill Padula
Monument Analytics Principal Dr. Bill Padula was cited in the USA Today article: “Bedsores kill over 60K people in the US each year. Amid COVID, experts worry more may be at risk” for his concern for increased pressure injuries due to COVID-19 hospitalizations.

November 18, 2020
Bill Padula
Monument Analytics Principal Dr. Bill Padula was cited in the USA Today article: “Coronavirus updates: US reaches 250K COVID deaths; New York City schools to close again; Kentucky toughens restrictions” for his concern that pressure injuries may increase due to COVID-19 hospitalizations.

November 13, 2020
Caleb Alexander
Monument Analytics Principal Dr. Caleb Alexander was quoted in The New York Times Article: “F.D.A. Panel Declines to Endorse Controversial Alzheimer’s Drug” for his participation on the federal panel of experts assessing aducanumab for treatment of Alzheimer’s disease.

November 12, 2020
Caleb Alexander
Monument Analytics Principal Dr. Caleb Alexander was quoted in The New York Times Article: “F.D.A. Panel Declines to Endorse Controversial Alzheimer’s Drug” for his participation on the federal panel of experts assessing aducanumab for treatment of Alzheimer’s disease.

November 9, 2020
Caleb Alexander
Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in the MedPage Today article: “Alzheimer’s Drug Debate Continues After Negative FDA Panel Review” — ‘This is a terribly important application to get right'” for his hope for safe and effective evidence of aducanumab for treatment of Alzheimer’s disease.

November 6, 2020
Caleb Alexander
Monument Analytics Principal Dr. Caleb Alexander was quoted in The New York Times Article: “F.D.A. Panel Declines to Endorse Controversial Alzheimer’s Drug” for his participation on the federal panel of experts assessing aducanumab for treatment of Alzheimer’s disease.

November 4, 2020
Monument Analytics
The Monument Analytics Team co-authored a piece in JAMA Network Open titled: “Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality.”

October 22, 2020
Caleb Alexander
Monument Analytics Principal Dr. Caleb Alexander was interviewed on Bloomberg Businessweek’s “Why Telemedicine Might Not Work for Everything.”

October 17, 2020
Bill Padula
Monument Analytics Principal Dr. Bill Padula was cited in The Regulatory Review Saturday Seminar Article: “Regulating Prescription Drug Costs” for his article from the Journal of Health Care Law and Policy titled: “State and Federal Policy Solutions to Rising Prescription Drug Prices in the U.S.”

October 14, 2020
Caleb Alexander
Monument Analytics Principal Dr. Caleb Alexander was interviewed by Verywell Health about challenges with telemedicine.

October 13, 2020
Caleb Alexander
Dr. Caleb Alexander’s paper, “Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US” in JAMA Network Open was featured in several news outlets including Medpage Today’s article “Cardiovascular Screenings Fall as Telehealth Moves In” and in Healio, “Despite surge in telehealth, primary care visits drop 21% amid COVID-19.”

October 5, 2020
Caleb Alexander
Dr. Caleb Alexander, Monument Analytics Principal and Co-Founder, was interviewed on HCPLive® about addressing shortcomings in the FDA’s opioid approval process.

October 2, 2020
Caleb Alexander, Omar Mansour
JAMA Network Open publishes a piece co-authored by Monument Analytics Principal and Co-Founder Dr. Caleb Alexander and Monument Analytics Manager Omar Mansour titled, “Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US.”

October 2, 2020
Bill Padula

Health Affairs Blog short series, “Higher Health Care Value Post COVID-19” features Dr. Bill Padula, Principal at Monument Analytics,  with his post on “Applying Value Assessment To The Health Care Sector For COVID-19.”

October 1, 2020
Caleb Alexander
HCPLive® interviews Dr. Caleb Alexander, Monument Analytics Principal, on his thoughts on the ongoing opioid epidemic.

Sept 30, 2020
Bill Padula, Mark Sculpher
Dr. William Padula, Monument Analytics Principal and Dr. Mark Sculpher, Monument Analytics Advisory Board Member, authored a piece in the Annals of Internal Medicine titled: “Ideas About Resourcing Health Care in the United States: Can Economic Evaluation Achieve Meaningful Use?

Sept 29, 2020
Ben Cohen
Dr. Ben Cohen, Monument Analytics Manager first-authored a piece in Health Economics titled: “Improved survival for individuals with common chronic conditions in the Medicare population.”

Sept 29, 2020
Bill Padula, Natalie Reid
Dr. William Padula, Monument Analytics Principal and Dr. Natalie Reid, Monument Analytics’ Director authored a piece in the Journal of Wound and Ostomy and Continence Nursing titled: “Wound, Ostomy, and Continence Nurses Could Be an Answer to the Economic Impact of Coronavirus.”

Sept 29, 2020
Caleb Alexander
Dr. Caleb Alexander, Monument Analytics’ Principal, co-authored a paper in the Annals of Internal Medicine titled: “Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018.”

August 4, 2020
Bill Padula, Shreena Malaviya, Ellen Hu, Jon Tierce
The Monument Analytics team authored a piece in Journal of Patient Safety and Risk Management titled: “The cost-effectiveness of sub-epidermal moisture scanning to assess pressure injury risk in U.S. health systems.”

July 22, 2020
Caleb Alexander
PBS News Hour interviewed Monument Analytics Principal Dr. Caleb Alexander about how the pandemic is complicating America’s addiction crisis.

July 6, 2020
Caleb Alexander
Kaiser Health News cited Dr. Caleb Alexander, Monument Analytics’ Principal,  as an expert in “Coronavirus Crisis Disrupts Treatment For Another Epidemic: Addiction.”

June 12, 2020
Bill Padula
Monument Analytics’ Principal Dr. Bill Padula co-authors a piece in PharmacoEconomics titled: “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US.”

June 9, 2020
Caleb Alexander
Dr. Caleb Alexander, Monument Analytics’ Principal, co-authored a piece in BMJ titled: “Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.”

May 30, 2020
Caleb Alexander
C-SPAN featured Monument Analytics’ Principal Dr. Caleb Alexander as an expert in “Dr. Caleb Alexander on COVID-19 Pandemic Impact on Addiction.”

May 18, 2020
Bill Padula
Monument Analytics Principal Dr. Bill Padula asked a Twitter poll about US spending duing the COVID-19 pandemic.

May 18, 2020
Bill Padula
Dr. William Padula, Monument Analytics’ Principal, co-authored a piece in Modern Healthcare on global budgets during Covid-19 in, “Global budgets offer financial cushion amid the coronavirus pandemic.

May 18, 2020
Monument Analytics
The Monument Analytics team in collaboration with our partners, Popper and Company, abstract and poster was accepted and presented at US ISPOR 2020: “Using Information From The Microbiome To Improve The Efficacy Of Selecting Therapeutic Options For Melanoma: A Cost-Effectiveness Analysis.”

May 18, 2020
Natalie Reid & Bill Padula
Monument Analytics’ Director, Dr. Natalie Reid, and Principal, Dr. Bill Padula’s abstract was accepted and presented at US ISPOR 2020, “Cooking At Home Can Save Money, Regardless Of Food Price: A Multilevel Analysis Of Meals Preapred Away From The Home On Diet Measures and Food Expenditures.

May 18, 2020
Natalie Reid & Bill Padula
Monument Analytics’ Director, Dr. Natalie Reid, and Principal, Dr. Bill Padula’s abstract was accepted and presented at US ISPOR 2020, “Smart Spending: Reallocating Americans’ Food Budgets To Save Costs And Improve Diet Quality.

May 18, 2020
Bill Padula
Dr. Bill Padula, Monument Analytics’ Principal, participates in ISPOR workshop, “Tailoring Opportunity Costs To State Budgets And Cost-Effectiveness Thresholds- How To Broaden The Impact Of Value Assessment In The U.S. With State And Commercial Payers.” Available online until June 30, 2020.

May 18, 2020
Bill Padula & Jon Tierce
Monument Analytics’ Principals, Bill Padula and Jonothan Tierce, host an ISPOR workshop, “Understanding Intricacies of Value Assessment – Learning How To Conduct Economic Evaluation Of Health Services And What Makes This Approach Different From Health Technology Assessment.” Available online until June 30, 2020.


May 14, 2020

Monument Analytics
The Monument Analytics team in collaboration with our partners, Popper and Company, abstract and poster was accepted and presented at US ISPOR 2020: “Using Information From The Microbiome To Improve The Efficacy Of Selecting Therapeutic Options For Melanoma: A Cost-Effectiveness Analysis.”


May 12, 2020

Caleb Alexander
Dr. Caleb Alexander, Prinicipal and Co-Founder, co-authors paper to protect the U.S. drug supply chain.

May 7, 2020
Monument Analytics
Monument Analytics’ Principal and Co-Founder, Dr. Caleb Alexander, was featured in a piece analyzing drug interactions for Covid-19 treatments in, “Drug-Drug Interactions Could Imperil Covid-19 Treatment.”

April 10, 2020
Caleb Alexander
Searching for an effective Covid-19 treatment: promise and peril, co-authored by Monument Analytic’s Co-Founder and Prinicipal, Dr. Caleb Alexander.

April 8, 2020
Bill Padula
A health care draft could help unemployment and front line burden in response to COVID-19, co-authored by Monument Analytic’s Principal, Dr. William Padula.

January/February 2019
Bill Padula
Dr. Padula, Principal at Monument Analytics, was featured in the ISPOR Member Spotlight in the feature, “Is Pharmacotherapy Enough to Manage The Opioid Crisis?”

November/December 2019
Jon Tierce, Francine Chingcuanco
Monument Analytics’ Jon Tierce and Fran Chingcuanco authored a piece titled “Improving Surgical Site Infection Prevention,” featuring an interview with Dr. Padula.